Live from IMS 2026: EXCALIBER-RRMM: First Phase 3 CELMoD Data With MRD-Negative CR as a Dual Primary Endpoint in RRMM
EHA2026: New Data on the Management of Anemia in Myelofibrosis
LIVE from ASCO26: New Data on CelMOD Therapy for Multiple Myeloma
Update on TTR Stabilizers in ATTR-CM: New Data from ACC 2026
Does nasal etripamil for PSVT drop blood pressure?
ATTR-CM : Updated epidemiology, diagnosis, sex disparities and latest TTR stabilizer data from 2026 so far!
Pain Management in Endometriosis: A Primer for NPs and PAs
The (Busy!) Year in Review: The Emergence of Aldosterone Synthase Inhibitors for Difficult-to-Control Hypertension in 2025
The (Busy!) Year in Review: The Emergence of Aldosterone Synthase Inhibitors for Difficult-to-Control Hypertension in 2025
ASH2025 Update on Management of Anemia in Patients with Myelofibrosis
Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists
Late-Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid-Lowering Therapies: Highlights Selected by the Experts
Update from AHA2025 on Management of ATTR-CM With TTR Stabilizers and Other Strategies
Update from AHA2025: New Data on Disease Modifying Therapy in the Management of ATTR Amyloidosis
Patient Self-Management of Acute PSVT: A Systematic Review of Etripamil Data from AHA25
The Nephrology Community’s Reception of New Phase 3 Data on Aldosterone Synthase Inhibitors for Difficult-to-Control Hypertension at ESC2025
The Nephrology Community’s Reception of New Phase 3 Data on Aldosterone Synthase Inhibitors for Difficult-to-Control Hypertension at ESC2025
Update on Management of Anaemia in Patients with Myelofibrosis
Update on Non-Statin Lipid-Lowering Therapies from ESC 2025
The Potential for Targeted Inhibition of Factor XI/XIa to Provide Safe and Effective Protection from a Secondary Ischemic Noncardioembolic Stroke